SCHEMBL16808669

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL25428148	0.74	TSHR (0.37)	CA12CA1CA2CA7CA9
	SCHEMBL25743158	0.74	CA12 (0.45)	CA12CA1CA2CA7CA9
	SCHEMBL16808671	0.73	CA12 (0.48)	CA12CA1CA2CA7CA9
	SCHEMBL23078652	0.71	CA12 (0.45)	CA12CA1CA2CA7CA9
	SCHEMBL28049117	0.70	ALDH1A1 (0.50)	MAPTKDM4ENPC1RAB9ALMNA
	SCHEMBL9515240	0.70	CYP3A4 (0.56)	CA12CA1CA2CA7CA9
	SCHEMBL12498091	0.70	CYP3A4 (0.56)	CA12CA1CA2CA7CA9
	SCHEMBL20223068	0.70	MAOB (0.39)	CA12CA1CA2CA7CA9
	SCHEMBL1914016	0.70	CA12 (0.48)	CA12CA1CA2CA7CA9
	SCHEMBL1914013	0.70	CA12 (0.48)	CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.